A Novel Nanobody Directed against Ovine Myostatin to Enhance Muscle Growth in Mouse
1
National and Local Joint Engineering Research Center of Targeted and Innovative Therapeutics, Chongqing Engineering Laboratory of Targeted and Innovative Therapeutics, Chongqing Key Laboratory of Kinase Modulators as Innovative Medicine, Chongqing Collaborative Innovation Center of Targeted and Innovative Therapeutics, College of Pharmacy & International Academy of Targeted Therapeutics and Innovation, Chongqing University of Arts and Sciences, Chongqing 402160, China
2
College of Animal Sciences, Shihezi University, Shihezi, Xinjiang 832000, China
3
College of Life Sciences, Shihezi University, Shihezi, Xinjiang 832000, China
4
College of Natural Science, NingXia University, YinChua 750000, China
*
Authors to whom correspondence should be addressed.
†
These authors Kepeng Ou, Youjian Li and Peng Wu contributed equally to this work.
Animals 2020, 10(8), 1398; https://doi.org/10.3390/ani10081398
Received: 20 July 2020
/
Revised: 2 August 2020
/
Accepted: 4 August 2020
/
Published: 11 August 2020
Simple Summary
Myostatin (MSTN) is a negative regulator of myogenesis, and various strategies have been used to improve livestock production by inhibiting MSTN. In this study, we developed a single-variable domain of the heavy chain antibody-recombinant MSTN nanobody (RMN) against MSTN. The selected RMN was expressed, purified, and assessed for its cytotoxicity, affinity, specificity, and the ability to inhibit MSTN. The results demonstrated that RMN could specifically detect and bind MSTN, further inhibit myostatin activity, as well as enhance muscle growth in mice.
Myostatin (MSTN) is a member of the transforming growth factor beta superfamily and is a negative regulator of myogenesis. It has been shown to function by controlling the proliferation of myoblasts. MSTN inhibition is considered as a promising treatment for promoting animal growth in livestock. Nanobodies, a special antibody discovered in camel, have arisen as an alternative to conventional antibodies and have shown great potential when used as tools in different biotechnology fields, such as diagnostics and therapy. In this study, we examined the effect of MSTN inhibition by RMN on the muscle growth of mice. The results showed that RMN could specifically detect and bind MSTN, as well as inhibit MSTN activity. A significant increase in skeletal muscle mass was observed after intramuscular injection of RMN into mice. Enhanced muscle growth occurred because of myofiber hypertrophy. These results offer a promising approach to enhance muscle growth that warrants further investigation in domestic animals.
View Full-Text
Keywords:
myostatin; nanobody; recombinant myostatin nanobody; muscle growth
▼
Show Figures
Figure 1
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited
MDPI and ACS Style
Ou, K.; Li, Y.; Wu, P.; Guo, J.; Hao, X.; Sheng, J.; Chen, C. A Novel Nanobody Directed against Ovine Myostatin to Enhance Muscle Growth in Mouse. Animals 2020, 10, 1398. https://doi.org/10.3390/ani10081398
AMA Style
Ou K, Li Y, Wu P, Guo J, Hao X, Sheng J, Chen C. A Novel Nanobody Directed against Ovine Myostatin to Enhance Muscle Growth in Mouse. Animals. 2020; 10(8):1398. https://doi.org/10.3390/ani10081398
Chicago/Turabian StyleOu, Kepeng, Youjian Li, Peng Wu, Jixing Guo, Xiujing Hao, Jinliang Sheng, and Chuangfu Chen. 2020. "A Novel Nanobody Directed against Ovine Myostatin to Enhance Muscle Growth in Mouse" Animals 10, no. 8: 1398. https://doi.org/10.3390/ani10081398
Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.
